The impact of smoking status on clopidogrel responsiveness in patients with coronary artery disease who undergo percutaneous coronary intervention [version 1; peer review: awaiting peer review]

HIGHLIGHTS

• who: Competing interests No competing et al. from the Department of Pharmacology and Therapeutics, College of Pharmacy, University of Jabbir ibn Hayyan, Al-Najaf, Iraq School of Agriculture, Biomedicine and Environment, La Trobe University, Melbourne, VIC, Australia have published the research: The impact of smoking status on clopidogrel responsiveness in patients with coronary artery disease who undergo percutaneous coronary intervention [version 1; peer review: awaiting peer review], in the Journal: (JOURNAL) of 05/04/2023
• what: This study was designed to examine whether smoking enhances clopidogrel responsiveness in patients who are clinically diagnosed with coronary . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.